Ana Paula Cabral de Araujo Lima

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Instituto de Biofísica Carlos Chagas Filho

Departamento:

Programa de Biofísica/I Biof

ORCID:

https://orcid.org/0000-0003-4631-2694


Formação:
  • University of Glasgow

    | Pós-Doutorado | 2008 - 2008
  • Universidade Federal do Rio de Janeiro

    | Pós-Doutorado | 1996 - 1997
  • McGill University

    Molecular Control of Cell Growth | Especialização | 1992 - 1992
  • McGill University

    Recent Advances in Molecular Genetics | Especialização | 1992 - 1992
  • McGill University

    Physiology of Blood I | Especialização | 1992 - 1992
  • McGill University

    Topics in Molecular Biology | Especialização | 1991 - 1991
  • McGill University

    Biology of Cancer | Especialização | 1991 - 1991
  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas (Biofísica) | Doutorado | 1990 - 1996
  • Universidade Federal do Rio de Janeiro

    | Graduação | 1986 - 1989
Laboratórios:
Nuvens de Palavras:
Artigos:
Nenhum artigo cadastrado
Eventos:

(0.00% eventos com DOI)

Titulo DOI Ano
Inhibitor of serine peptidase 2 (ISP2) of Leishmania major modulates parasite interaction with neutrophils 2011
Substrate inhibition and allosteric modulation of brucipain by heparan sulfate 2011
The inhibition of cysteine cathepsins in embryonic stem cells promotes neual differentiation 2011
Leishmania major inhibitor of serine peptidases, ISP2, prevents the activation of mammalian PKR, promoting parasite survival in macrophages 2011
Substrate inhibition and allosteric modulation of brucipain by heparan sulfate 2011
Cruzipain promotes Trypanosoma cruzi adhesion to Rhodnius prolixus midgut 2011
Trypanosoma cruzi invades host cells through the activation of endothelin and bradykinin receptors: a converging pathwayleading to chagasic vasculopathy 2011
Characterization of serine peptidase inhibitor (ISP2) of Trypanosoma cruzi 2011
Characterisation of the putative sialoglyco metallopeptidase-like gene of Leishmania major 2011
Cruzipain promotes Trypanosoma cruzi adhesion to Rhodnius prolixus explanted midguts 2010
Leishmania major encoded inhibitors of serine peptidase (ISPs) modulate de uptake and release of parasite from murine neutropils 2010
Infuence of Ecotin-like serine peptidase inhibitors of Leishmania major in parasite internalization and survival in murine dendritic cells 2010
Role of natural inhibitor of cysteine peptidase in Trypanosoma brucei. 2009
Influence on host cell invasion by serine peptidase inhibitor (ISP2) of Trypanosoma cruzi. 2008
Influence of inhibitors of serine peptidases of Leishmania major in the early stage of infection. 2008
Intracellular sorting of phosphoglucomutase to glycosomes in Trypanosoma cruzi. 2008
ICP regulation of Trypanosoma brucei cysteine peptidases: influence on parasite traversal of the blood brain barrier. 2007
Modulation of host neutrophil elastase by ecotin-like serine peptidase inhibitors (ISP) of Leishmania major: influence on parasite infectivity and survival. 2007
Characterization of Trypanosoma cruzi p67: a putative reservosome marker. 2007
The phosphoglucomutase (PGM) of Trypanosoma cruzi: mapping the import motifs responsible for the intracellular sorting to glycosomes. 2007
Characterization of the serine peptidase inhibitor (ISP2) of Trypanosoma cruzi. 2007
Distinct pathways of smooth muscle invasion by Trypanosoma cruzi Dm28 trypomastigotes: Differential roles of G Protein-coupled receptors, adenylyl cyclase and PI3 kinase mediated signaling. 2006
African trypanosomes traversal of the human blood-brain barrier requires cysteine protease mediated calcium signaling. 2006
Structural basis for the inhibitory function of chagasin: Different requirements for the inhibition of parasite versus host cysteine proteases. 2006
Role of ecotin-like serine peptidase inhibitors of Leishmania major in parasite internalization and survival in murine macrophages. 2006
Phosphoglucomutase (PGM) is located in the glycosomes of Trypanosoma cruzi. 2006
Molecular and biochemical characterization of the acyl-CoA-dependent ceramide synthase gene in Trypanosoma cruzi. 2006
Antileishmanial chalcones with increased in vitro activity against African trypanosomes. 2006
Trypanosomatid drug resistance: some cellular facets. 2006
Studies on the sub-cellular localization of phosphoglucomutase (PGM) in Trypanosoma cruzi. 2005
Alterations in traffic and pro-cruzipain maturation in Trypanosoma cruzi overexpressing chagasin. 2005
Studies on the chagasin family of cysteine peptidase inhibitors. 2005
Alterations in Traffic, Lipid Biosynthesis and Pro-Cruzipain Maturation in Trypanosoma cruzi Overexpressing Chagasin. 2005
The Substrate specificity of the cysteine peptidase of Trypanosoma b. brucei, brucipain and its inactivation by natural cysteine peptidase inhibitors. 2005
Potent inhibition of cathepsin F and of cysteine proteases from trypanosomes (cruzipain and brucipain) by the propeptide of cruzipain. 2005
Interplay between parasite cysteine proteases and the host kinin system modulates vascular leakage and macrophage infection by promastigotes of the Leishmania donovani complex. 2005
Brucipain takes a tryp across the Blood-Brain Barrier. 2005
Chagasin contributes to post-transcriptional regulation of cruzipain function. 2004
Cloning and heterologous expression of the cysteine protease from Trypanosoma brucei brucei (brucipain) and characterization of temperature dependent substrate inhibition. 2004
High affinity inhibition of cysteine proteases from diverse pathogenic trypanosomatids by the pro domain of cruzipain. 2004
Heterologous expression of Trypanosoma cruzi phosphoglucomutase (PGM) in Saccharomyces cerevisiae and functional complementation of yeast pgm null mutant. 2004
The activation of precursor forms of the T. cruzi main cysteine protease, cruzipain, is modulated by glycosaminoglicans and by mildly acidic pH. 2004
Modulation of the cysteine protease of T. brucei brucei (brucipain) by glycosaminoglicans and enzyme inactivation by the N-terminal domain (pro domain) of cruzipain. 2004
Role of dibucaine in the endocytic and exocytic pathway of epimastigote forms of Trypanosoma cruzi. 2004
Analysis of the phosphoglucomutase (PGM) gene among different stocks of T. cruzi. 2004
Chronic heart fibrosis is attenuated in B1 knockout mice infected by Trypanosoma cruzi. 2004
Cloning and expression of a recombinant cysteine protease (TFCP1) from Thrithrichomonas foetus. 2003
Post-Transcriptional regulation of cruzipain by the endogenous inhibitor chagasin 2003
Cloning, expression and characterization of the cysteine proteases from Trypanosoma brucei brucei (brucipain) and Leishmania donovani. 2003
Potent inhibition of trypanosomatid cysteine proteases by the pro domain of cruzipain. 2003
Cloning and characterization of the phosphoglucomutase (PGM) gene from Trypanosoma cruzi. 2003
Chagasin regulates cruzipain activity, maturation and intracellular traffic in Trypanosoma cruzi. 2003
Targeting of Trypanosoma cruzi cysteine proteinases by synthetic inhibitors depends on endocytosis. 2002
Heparan sulfate modulates kinin release by Trypanosoma cruzi through the activity of cruzipain. 2002
Maturation of pro-cruzipain1 by cruzipain2: Evidence for trans-activation "in vivo". 2002
Over-expression of chagasin, a cysteine protease inhibitor of T. cruzi, modulates the maturation of pro-cruzipain and the suceptibility of epimastigotes to synthetic cysteine protease inhibitors. 2002
Characterization of chagasin-like cysteine protease inhibitors in Leishmania amazonensis, Leishmania donovani and Tritrichomonas foetus. 2001
Heparan sulfate modulates kinin-release by Trypanosoma cruzi through the activity of cruzipain. 2001
Activation of the inducible B1-kinin receptor (B1) by Trypanosoma cruzi: host cell susceptibility. 2001
Infectivity of Trypanosoma cruzi trypomastigotes depends on the activity of extracellular cruzipain. 2001
Correlation between cruzipain expression and Trypanosoma cruzi infectivity "in vitro" 2000
Signaling through the inducible bradykinin receptor (B1R) increases host cell suceptibility to invasion by Trypanosoma cruzi. 2000
Specificity determinants of cruzipain isoforms 2000
Protozoa cystine-proteases as markers for the study of endocytic function in primitive eucaryotic cells 2000
Substrate specificity of a major cysteine proteinase from Plasmodium falciparum (falcipain) characterized by fluorescent internally quenched substrates. 2000
Molecular dynamics simulation of cruzain and cruzipain 2: the S2 specificity pocket. 2000
Molecular basis of activation of vascular endothelium by Trypanosoma cruzi: role of kininogens, kinins and bradykinin receptors. 2000
Characterization of the substrate specificity of cysteine protease isoforms from Trypanosoma cruzi: a comparative study between cruzipain 2 and cruzain. 1999
Expression of cruzipain and of a cathepsin B like target (Tc-cb) is inverted in a Trypanosoma cruzi cell line displaying resistance to synthetic inhibitors of cysteine proteinases. 1999
Gene transfection of Trypanosoma cruzi with a minor cysteine proteinase isoform (cruzipain 2) but not cruzain, potentiates trypomastigote infectivity in mammalian cells "in vitro". 1999
Molecular modeling of the inhibition of cysteine proteases from Trypanosoma cruzi by E-64. 1998
Molecular characterization of chagasin, a Trypanosoma cruzi inhibitor of papain like cysteinyl proteinases. 1998
The transfection of Trypanosoma cruzi cell lines with the gene of the cysteine protease isoform cruzipain 2 enhances parasite infectivity in host cells. 1998
Trypanosoma cruzi resistance to synthetic inhibitors of cysteine-proteinases correlates with changes in the expression of target enzymes and membrane permeability. 1998
Recombinant cysteine protease isoforms from Trypanosoma cruzi (Cruzain and cruzipain 2) show marked differences to inhibitor sensitivity. 1998
Inhibition studies of cysteine proteases from Trypanosoma cruzi by molecular modeling. 1998
Immunochemical characterization of cruzipain isoforms during Trypanosoma cruzi development. 1998
Preliminary characterization of Trypanosoma cruzi cell lines transfected with the cysteine protease isoform cruzipain 2. 1997
Multiple mechanisms determine drug resistance against peptidyl-based inhibitors of Trypanosoma cruzi. 1997
Characterization of a Trypanosoma cruzi population resistant to synthetic irreversible cysteine protase inhibitors. 1996
The kinin releasing activity of cysteinyl proteinases from Trypanosoma cruzi: a factor of parasite virulence and pathogenicity ? 1996
The Major Cysteine Proteinase From Trypanosoma Cruzi: Phenotypic Cha- Racterization Of A Parasite Sub-Population Selected For Resistance Against Irreversible Synthetic Inhibitors. 1995
The Minor Cysteine Proteinase From Trypanosoma Cruzi:Identification Inparasite Population Selected For Resistance To Synthetic Inhibitors. 1995
Synthesis cf coumarin-containing peptides and their hydrolysis by cysteine proteases. 1995
Preliminary Characterization Of Recombinant Cruzipain 2, A New Cystei-Ne Protease Isoform From Trypanosoma Cruzi. 1994
Structure And Functional Diversities In Trypanosoma Cruzi Cysteinyl Protease. 1994
Genetic Diversity Of Cysteinyl Proteinases From Trypanosoma Cruzi. 1993
Temperature dependent substrate inhibition of the cysteine protease (Gp57/51) from Trypanosoma cruzi. 1992
Cloning and expression of cruzipain 2, a new cysteine protease of Trypanosoma cruzi. 1992
Cloning Of Cruzipain 2, A New Cysteine Protease From Trypanosoma Cruzi 1992
Publicações:
Minha Rede: